I’m unable to verify a single most significant biotechnology market story from the last 24 hours because I do not have access to live web results in this turn. Given your requirement for strictly real, verifiable news from the last 24 hours, I should not fabricate or infer a headline, market reaction, or data points.

If you want, I can still help in one of two ways: I can draft a publication-ready biotechnology market article based on a specific verified news item you provide, or I can produce a fully structured template for a biotech market brief that you can populate once a live source is available.

To meet your standards accurately, I need a verifiable story, such as an FDA decision, a late-stage trial readout, a deal announcement, earnings from a large-cap biotech name, or a sector-moving policy headline published within the last 24 hours.